In this interview, Magnus Back, MD, PhD delves into the role of SPMs in advancing cardiovascular disease treatment. He highlights their potential to enhance current therapies by effectively resolving inflammation. Dr. Back explains how insights from animal models are translating into human treatments, particularly focusing on the effects of SPMs on atheerosclerotic lesions and aortic valve stenosis. He also addresses the challenges and opportunitis of integrating these findings into practical patient care, underscoring the significant impacts of his research on heart health.
Magnus Back, MD, PhD, is a Professor of Cardiology at Karolinska Institute
